Q1 2012

Source filing unavailable

Q1 2012 · —

Revenue

$6.27M

no prior Q1 2011 on file

Net Income

-$4.63M

no prior Q1 2011 on file

EPS Diluted

-$1.98

no prior Q1 2011 on file

Operating Income-$5,264,000—

Margins · derived

Operating margin-84.0%

Net margin-73.9%

Same quarter

no prior Q1 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR